Data / Drug companies / Vive Health LLC
Vive Health LLC: 14 products in the FDA NDC directory, labeler code 84722
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Vive Health LLC (labeler code 84722) lists 14 products in the FDA National Drug Code Directory, covering 8 finished drugs by generic name. By type: 14 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on July 1, 2026.
The request: Watch Vive Health LLC (FDA labeler code 84722): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 84722
- Products in commercial distribution
- 14
- Packages
- 14
- Finished drugs by generic name
- 8
- Prescription products
- 0
- Over the counter products
- 14
- Flagged as original packager
- 14 of 14 products that carry the flag
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- September 20, 2024
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 14 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 14 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| White petrolatum | 3 | 67 |
| Hydrocortisone | 2 | 171 |
| Miconazole | 2 | 5 |
| Bacitracin zinc, neomycin sulfate, polymyxin b sulfate | 2 | 44 |
| Lidocaine, menthol | 2 | 34 |
| Clotrimazole | 1 | 98 |
| Dimethicone | 1 | 69 |
| Zinc oxide | 1 | 595 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Ointment | 6 | 42.9% |
| Cream | 4 | 28.6% |
| Patch | 2 | 14.3% |
| Powder | 1 | 7.1% |
| Jelly | 1 | 7.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Azole Antifungal | 3 |
| Corticosteroid | 2 |
| Aminoglycoside Antibacterial | 2 |
| Polymyxin-class Antibacterial | 2 |
| Amide Local Anesthetic | 2 |
| Antiarrhythmic | 2 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Dimethicone skin protectant | 84722-3078 | Cream | Over the counter monograph drugs | July 1, 2026 |
| Lidocaine | 84722-3072 | Patch | Over the counter monograph drugs | December 17, 2025 |
| Antifungal | 84722-3060 | Ointment | Over the counter monograph drugs | April 28, 2025 |
| Antifungal | 84722-3059 | Cream | Over the counter monograph drugs | April 28, 2025 |
| Antifungal | 84722-3057 | Powder | Over the counter monograph drugs | March 21, 2025 |
| VITAMIN A and D | 84722-3033 | Ointment | Over the counter monograph drugs | January 16, 2025 |
| VITAMIN A and D | 84722-3033 | Ointment | Over the counter monograph drugs | January 16, 2025 |
| Zinc oxide | 84722-3036 | Ointment | Over the counter monograph drugs | December 2, 2024 |
| Petroleum | 84722-3035 | Jelly | Over the counter monograph drugs | October 17, 2024 |
| Hydrocortisone | 84722-3031 | Cream | Over the counter monograph drugs | October 10, 2024 |
| Hydrocortisone | 84722-3031 | Cream | Over the counter monograph drugs | October 9, 2024 |
| Lidocaine | 84722-3041 | Patch | Over the counter monograph drugs | October 1, 2024 |
| Triple antibiotic | 84722-3032 | Ointment | Over the counter monograph drugs | October 1, 2024 |
| Triple antibiotic | 84722-3032 | Ointment | Over the counter monograph drugs | September 20, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.